Get the Stockscreener App
1.48
10.84%
-0.18
After Hours:
1.49
0.01
+0.68%
Harvard Bioscience Inc stock is traded at $1.48, with a volume of 493.02K.
It is down -10.84% in the last 24 hours and down -32.42% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
See More
Previous Close:
$1.66
Open:
$1.67
24h Volume:
493.02K
Relative Volume:
2.41
Market Cap:
$64.28M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-7.40
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
-16.38%
1M Performance:
-32.42%
6M Performance:
-49.14%
1Y Performance:
-68.38%
1-Day Range:
$1.46
$1.6719
1-Week Range:
$1.46
$1.80
52-Week Range:
$1.46
$4.93
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
1.48 | 64.28M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
JPMorgan Chase & Co. Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.7 amid market challenges - Investing.com India
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in January - MarketBeat
Assenagon Asset Management S.A. Sells 132,516 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges - Investing.com Canada
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges By Investing.com - Investing.com South Africa
Microelectrode Array In Vitro Market to Reach US$ 25.67 Million by 2031, Driven by Neuroscience and Animal Testing Alternatives - GlobeNewswire Inc.
Barclays PLC Has $157,000 Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Acquired by Barclays PLC - Defense World
bioMérieux Gains FDA Clearance for Tropical Fever Test - MSN
One Harvard Bioscience Insider Raised Their Stake In The Previous Year - Yahoo Finance
Harvard Bioscience (NASDAQ:HBIO) Stock Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Jane Street Group LLC Sells 37,349 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding - dallasinnovates.com
LeddarTech Reports on Participation in CES 2025 - The Manila Times
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference - The Manila Times
Harvard Bioscience CEO to Present at Sidoti Micro Cap Conference on January 22 - StockTitan
Further weakness as Harvard Bioscience (NASDAQ:HBIO) drops 11% this week, taking three-year losses to 69% - Simply Wall St
HBIO stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa
HBIO stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
Harvard Bioscience, Inc. (NASDAQ:HBIO) Position Boosted by Barclays PLC - Defense World
Geode Capital Management LLC Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria
HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance
BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World
Lexaria Bioscience Taps Harvard Medical Expert to Accelerate GLP-1 & Hypertension Drug Development - StockTitan
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World
Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com
Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
Harvard Bioscience files $100M mixed securities shelf - MSN
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
Prepacked Chromatography Columns Market Size Is Expected To - GlobeNewswire
272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat
Ayla Majid becomes first South Asian ACCA president - The Accountant Online
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):